|Daily Range||$24.50 - $25.14|
|52-Week Range||$19.10 - $68.76|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||735,598|
|Current FY EPS||-$1.09|
Aegerion Pharmaceuticals, Inc. (AEGR) Description
Aegerion Pharmaceuticals, Inc. Website: http://www.aegerion.com/
Aegerion Pharmaceuticals, MannKind Corp., and VIVUS, Inc. have all attracted short sellers in droves this year. With each company facing serious headwinds, should investors avoid these struggling biotechs?
Soros Fund Management opened a position in the struggling biotech Aegerion Pharmaceuticals in the third quarter, even while the drugmaker's revenue estimates continued to plummet. Should retail investors follow his lead into this beaten down biotech?